Q1 2025 Management View CEO Joe Papa highlighted significant progress in Emergent's multiyear turnaround plan, focusing on stabilizing operations, streamlining costs, and driving sustainable growth.

Data from an open-label trial showed that foralumab treatment eased fatigue and lessened disability for some people with ...

LTR Pharma (ASX:LTP) has joined forces with Strategic Drug Solutions to developed a nasal spray to treat oesophageal motility disorders.

Kindeva, a global contact development and manufacturing organization, was joined by Lieutenant Governor Jacqueline Coleman ...

For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

ARS Pharmaceuticals (NASDAQ:SPRY) partners with ALK to co-promote neffy, an epinephrine nasal spray, to 9,000 pediatricians.

SACRAMENTO – Governor Newsom announced that individual twin-packs of CalRx®-branded over-the-counter (OTC) naloxone HCL 4 mg nasal spray are now available to all Californians at a low price of $24 per ...

It’s election this weekend in Australia, and we’re all preparing to dictate what the next three years of our lives will look ...

Emergent BioSolutions signed an agreement worth around $65 million to supply the Ontario Ministry of Health with Narcan nasal spray. The contract will last a maximum of three years and supports the ...

Previously called STS101, the company said Wednesday that the drug’s brand name is Atzumi and is indicated for acute migraine ...

It’s the best bottle of bug spray we found after testing over 25 repellents and talking to everyone from the EPA to the American Mosquito Control Association. This EPA-approved picaridin formula ...